US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 1.1000
  • -0.0300-2.65%
Close May 20 16:00 ET
  • 1.0900
  • -0.0100-0.91%
Post 19:59 ET
5.44MMarket Cap-56P/E (TTM)

TC BioPharm Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Total revenue
0
0
0
0
94.30%3.84M
0.00%1.98M
0.00%494.67K
494.66K
-42.26%1.98M
494.67K
Operating revenue
--0
--0
--0
--0
94.30%3.84M
0.00%1.98M
0.00%494.67K
--494.66K
-42.26%1.98M
--494.67K
Cost of revenue
Gross profit
Operating expense
-17.38%3.44M
-10.60%14.24M
3.52M
4.17M
72.03%15.93M
11.32%9.26M
33.78%2.82M
2.65M
-17.38%8.32M
2.11M
Selling and administrative expenses
-3.98%2.14M
-22.41%6.47M
--1.38M
--2.23M
168.14%8.34M
40.88%3.11M
111.76%1.18M
--1.05M
-26.80%2.21M
--555.56K
-General and administrative expense
-3.98%2.14M
-22.41%6.47M
--1.38M
--2.23M
168.14%8.34M
40.88%3.11M
111.76%1.18M
--1.05M
-26.80%2.21M
--555.56K
Research and development costs
-32.85%1.3M
2.36%7.77M
--2.14M
--1.93M
23.32%7.59M
-7.83%6.16M
4.99%1.65M
--1.6M
-22.45%6.68M
--1.57M
Other operating expenses
----
----
----
----
----
98.88%-6.38K
96.83%-435
--0
63.54%-569.2K
---13.71K
Operating profit
17.38%-3.44M
-17.84%-14.24M
-3.52M
-4.17M
-65.97%-12.08M
-14.86%-7.28M
-44.12%-2.33M
-2.16M
4.54%-6.34M
-1.61M
Net non-operating interest income expense
98.77%-83.03K
-96.40%-6.75M
-1,081.49%-3.44M
-2,692.96%-1.92M
-1.15M
-14.80%-291.03K
-68.81K
Non-operating interest income
----
----
----
----
----
-96.79%33
-98.78%5
--7
-95.30%1.03K
--410
Non-operating interest expense
----
-98.77%83.03K
----
----
96.40%6.75M
1,077.33%3.44M
2,676.43%1.92M
--1.15M
6.05%292.06K
--69.22K
Other net income (expense)
-99.71%9.06K
-53.64%7.33M
4.35M
3.13M
470.60%15.8M
-4.26M
-271.35K
Gain on sale of security
-99.64%11.45K
-50.00%7.97M
--4.98M
--3.15M
473.89%15.94M
---4.26M
---271.35K
----
----
----
Other non- operating income (expenses)
86.59%-2.39K
-360.19%-645.85K
---628.05K
---17.79K
---140.34K
----
----
----
----
----
Income before tax
-231.68%-3.43M
-130.61%-7M
688.49K
-1.03M
79.75%-3.03M
-126.00%-14.98M
-168.52%-4.52M
-7.3M
3.83%-6.63M
-1.68M
Income tax
72.31%-110.74K
36.70%-1.09M
-300K
-400K
-22.20%-1.72M
-20.10%-1.41M
-71.04%-620.09K
-274.94K
-41.87%-1.17M
-362.54K
Net income
-423.20%-3.32M
-349.68%-5.91M
988.49K
-634.91K
90.32%-1.31M
-148.74%-13.58M
-195.27%-3.9M
-7.03M
10.05%-5.46M
-1.32M
Net income continuous Operations
-423.20%-3.32M
-349.68%-5.91M
--988.49K
---634.91K
90.32%-1.31M
-148.74%-13.58M
-195.27%-3.9M
---7.03M
10.05%-5.46M
---1.32M
Minority interest income
Net income attributable to the parent company
-423.20%-3.32M
-349.68%-5.91M
988.49K
-634.91K
90.32%-1.31M
-148.74%-13.58M
-195.27%-3.9M
-7.03M
10.05%-5.46M
-1.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-423.20%-3.32M
-349.68%-5.91M
988.49K
-634.91K
90.32%-1.31M
-148.74%-13.58M
-195.27%-3.9M
-7.03M
10.05%-5.46M
-1.32M
Basic earnings per share
64.52%-2.2
49.74%-19.2
2.998
-6.2
94.50%-38.2
-257.03%-694.4918
-323.82%-199.5161
-359.5044
10.05%-194.5202
-47.076
Diluted earnings per share
64.52%-2.2
49.74%-19.2
2.998
-6.2
94.50%-38.2
-257.03%-694.4918
-323.82%-199.5161
-359.5044
10.05%-194.5202
-47.076
Dividend per share
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Total revenue 000094.30%3.84M0.00%1.98M0.00%494.67K494.66K-42.26%1.98M494.67K
Operating revenue --0--0--0--094.30%3.84M0.00%1.98M0.00%494.67K--494.66K-42.26%1.98M--494.67K
Cost of revenue
Gross profit
Operating expense -17.38%3.44M-10.60%14.24M3.52M4.17M72.03%15.93M11.32%9.26M33.78%2.82M2.65M-17.38%8.32M2.11M
Selling and administrative expenses -3.98%2.14M-22.41%6.47M--1.38M--2.23M168.14%8.34M40.88%3.11M111.76%1.18M--1.05M-26.80%2.21M--555.56K
-General and administrative expense -3.98%2.14M-22.41%6.47M--1.38M--2.23M168.14%8.34M40.88%3.11M111.76%1.18M--1.05M-26.80%2.21M--555.56K
Research and development costs -32.85%1.3M2.36%7.77M--2.14M--1.93M23.32%7.59M-7.83%6.16M4.99%1.65M--1.6M-22.45%6.68M--1.57M
Other operating expenses --------------------98.88%-6.38K96.83%-435--063.54%-569.2K---13.71K
Operating profit 17.38%-3.44M-17.84%-14.24M-3.52M-4.17M-65.97%-12.08M-14.86%-7.28M-44.12%-2.33M-2.16M4.54%-6.34M-1.61M
Net non-operating interest income expense 98.77%-83.03K-96.40%-6.75M-1,081.49%-3.44M-2,692.96%-1.92M-1.15M-14.80%-291.03K-68.81K
Non-operating interest income ---------------------96.79%33-98.78%5--7-95.30%1.03K--410
Non-operating interest expense -----98.77%83.03K--------96.40%6.75M1,077.33%3.44M2,676.43%1.92M--1.15M6.05%292.06K--69.22K
Other net income (expense) -99.71%9.06K-53.64%7.33M4.35M3.13M470.60%15.8M-4.26M-271.35K
Gain on sale of security -99.64%11.45K-50.00%7.97M--4.98M--3.15M473.89%15.94M---4.26M---271.35K------------
Other non- operating income (expenses) 86.59%-2.39K-360.19%-645.85K---628.05K---17.79K---140.34K--------------------
Income before tax -231.68%-3.43M-130.61%-7M688.49K-1.03M79.75%-3.03M-126.00%-14.98M-168.52%-4.52M-7.3M3.83%-6.63M-1.68M
Income tax 72.31%-110.74K36.70%-1.09M-300K-400K-22.20%-1.72M-20.10%-1.41M-71.04%-620.09K-274.94K-41.87%-1.17M-362.54K
Net income -423.20%-3.32M-349.68%-5.91M988.49K-634.91K90.32%-1.31M-148.74%-13.58M-195.27%-3.9M-7.03M10.05%-5.46M-1.32M
Net income continuous Operations -423.20%-3.32M-349.68%-5.91M--988.49K---634.91K90.32%-1.31M-148.74%-13.58M-195.27%-3.9M---7.03M10.05%-5.46M---1.32M
Minority interest income
Net income attributable to the parent company -423.20%-3.32M-349.68%-5.91M988.49K-634.91K90.32%-1.31M-148.74%-13.58M-195.27%-3.9M-7.03M10.05%-5.46M-1.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -423.20%-3.32M-349.68%-5.91M988.49K-634.91K90.32%-1.31M-148.74%-13.58M-195.27%-3.9M-7.03M10.05%-5.46M-1.32M
Basic earnings per share 64.52%-2.249.74%-19.22.998-6.294.50%-38.2-257.03%-694.4918-323.82%-199.5161-359.504410.05%-194.5202-47.076
Diluted earnings per share 64.52%-2.249.74%-19.22.998-6.294.50%-38.2-257.03%-694.4918-323.82%-199.5161-359.504410.05%-194.5202-47.076
Dividend per share
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Audit Opinions --Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg